Pacific Biosciences of California, Inc. (PACB) News
Follow Pacific Biosciences of California, Inc. (PACB) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 16 public stories across 10 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
PacBio 3Q 2026: Revenue $40.56M, EPS ($0.12) — 10-Q Summary
PacBio’s third-quarter revenue rose 6% year over year, while its net loss narrowed slightly. Higher instrument and service revenue lifted sales, but increased cost of revenue—partly from contract manufacturer exit costs,
EARNINGS | Nov 05, 2026, 10:02 PM UTC
M
Pacific Biosciences reports third-quarter revenue of $40.6 million
EQUITY | Nov 04, 2026, 09:07 PM UTC
M
Pacific Biosciences Reports $37.8M Third-Quarter Loss
EQUITY | Nov 04, 2026, 09:07 PM UTC
M
Pacific Biosciences reports Q3 loss per share
EQUITY | Nov 04, 2026, 09:07 PM UTC
L
PacBio and Verily announce multi-year strategic collaboration
The collaboration aims to scale long-read genomics for biomedical AI.
EQUITY | Oct 19, 2026, 01:05 PM UTC
M
PacBio to Report Third-Quarter 2026 Results on November 4
EQUITY | Oct 14, 2026, 08:05 PM UTC
M
PacBio Announces AI Drug-Discovery Partnership with TychoBio
PacBio (PACB) has announced a partnership with TychoBio to advance AI-based drug discovery efforts. This news comes after an eight-session rally that saw PACB shares more than double in value.
EQUITY | Oct 06, 2026, 03:24 PM UTC
H
Apogee Enterprises Posts Upbeat Q2 Earnings, Joins Constellation Energy, Freshworks And Other Big Stocks Moving Higher On Tuesday
U.S. stocks were higher, with the Dow Jones index surging over 250 points on Tuesday. Shares of Apogee Enterprises Inc (NASDAQ: APOG ) rose sharply after the company announced better-than-expected second-quarter financia
LIVE | Oct 06, 2026, 02:20 PM UTC
H
Progress Software, Nft And Other Big Stocks Moving Lower In Thursday’s Pre-Market Session
U.S. stock futures were mixed this morning, with the Dow futures falling around 200 points on Thursday. Shares of Progress Software Corp (NASDAQ: PRGS ) fell sharply in pre-market trading after the company reported third
LIVE | Oct 01, 2026, 12:01 PM UTC
L
Why PacBio (PACB) Stock Is Trading Up Today
What Happened? Shares of genomics company Pacific Biosciences of California NASDAQ:PACB jumped 5.8% in the afternoon session after genomics provider Sampled announced a five-year contract worth up to $27.1 million from t
EQUITY | Sep 28, 2026, 08:09 PM UTC
L
UBS cuts Pacific Biosciences price target to $1.35 from $1.50
UBS cut its price target for Pacific Biosciences to $1.35 per share from $1.50, according to Benzinga ratings actions.
EQUITY | Sep 09, 2026, 06:18 PM UTC
L
PacBio to participate in Morgan Stanley 24th Global Healthcare conference fireside chat
PacBio said management will participate in a fireside chat at the Morgan Stanley 24th Annual Global Healthcare Conference on Tuesday, Sept. 2026.
EQUITY | Sep 03, 2026, 08:07 PM UTC
L
PacBio to Participate in Morgan Stanley Global Healthcare Conference
PacBio will participate in the Morgan Stanley 24th Annual Global Healthcare Conference.
EQUITY | Sep 03, 2026, 08:06 PM UTC
L
Pacific Biosciences Lowers FY2026 Sales Guidance from $165.000M-$175.000M to $155.000M-$165.000M vs $166.790M Est
Pacific Biosciences (NASDAQ: PACB ) lowers FY2026 sales outlook from $165.000 million-$175.000 million to $155.000 million-$165.000 million vs $166.790 million estimate.
EARNINGS | Aug 05, 2026, 08:29 PM UTC
M
PacBio Appoints Mark Van Oene CEO
PacBio appoints new CEO
EQUITY | Aug 05, 2026, 08:08 PM UTC
M
PacBio Upgrades Vega System
PacBio upgrades Vega system with faster runs
EQUITY | Aug 05, 2026, 01:05 PM UTC